CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the CFO of the Company, Gitte Lund Henriksen, has acquired 2 500 shares in CS MEDICA through several transactions, at an average price of 10,75, amounting to a total value of 27 250 DKK.

CFO and board member of CS MEDICA, Gitte Lund Henriksen, has purchased 2 500 shares in the open market at an average price of DKK 10,75 per share, corresponding to a total purchase of 27 250 DKK. The transaction has been disclosed in the Danish financial supervisory register. Following the transaction, Gitte Lund Henriksen owns 4 039 500 CS MEDICA shares.

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.

Tags: